On March 21, insulins from Russian company GEROPHARM arrived in Syria. These medicines are meant to support diabetes patients who suffered from the recent earthquake. More than 31,000 vials of rapid-acting recombinant human insulin were delivered as humanitarian aid to the Syrian people.
Diabetes mellitus prevalence in Syria is quite high: according to official statistics, more than 1.5 million people are diagnosed with this disease. This is more than 13 % of the adult population of Syria.
Over several years of the crisis in Syria, patients there have been experiencing difficulties accessing good-quality medicines and medical care. The disastrous earthquake in February only made the situation worse. Many hospitals and diabetes centers were destroyed and medicine procurement and delivery logistics were disrupted.
Notwithstanding the difficulties, insulins were delivered through the contribution to the project by the Ministry of Industry and Trade of the Russian Federation, the Russian Trade Mission in Syria, and its Head Georgi Asatryan, in particular. Through their invaluable efforts, insulins were successfully received and transferred to Syria.